Dr. Sarah B. Mulkey is a prenatal-neonatal neurologist in the Division of Prenatal Pediatrics at Children’s National Hospital and the site Principal Investigator at Arkansas Children’s Hospital for the Phase II clinical trial for erythropoietin as a neuroprotective agent for neonatal hypoxic-ischemic encephalopathy. She earned a medical degree from the Florida State University College of Medicine and became the first and only dedicated neonatal neurologist in Arkansas providing state-of-the-art neurologic care to newborns with a variety of complex neurologic. Her research interests include brain injury in the fetus and newborn, brain growth and development, and neurodevelopmental outcomes in newborns at risk for brain injury.